Systems Biology Strategy Reveals PKCδ is Key for Sensitizing TRAIL-Resistant Human Fibrosarcoma

Cancer cells are highly variable and largely resistant to therapeutic intervention. Recently, the use of the tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induced treatment is gaining momentum due to TRAIL’s ability to specifically target cancers with limited effect on normal cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Kentaro, Tabata, Sho, Piras, Vincent, Tomita, Masaru, Selvarajoo, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283611/
https://www.ncbi.nlm.nih.gov/pubmed/25601862
http://dx.doi.org/10.3389/fimmu.2014.00659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283611/
https://www.ncbi.nlm.nih.gov/pubmed/25601862
http://dx.doi.org/10.3389/fimmu.2014.00659

Ejemplares similares